At Imbrium Ventures, our mission is to ignite disruptive innovation in technology and healthcare.

We've empowered early-stage companies to flourish and achieve significant milestones, including successful IPOs. Our commitment to these sectors reflects a deep-rooted belief in their potential to revolutionize technology and healthcare. Our recent focus has been on supporting trailblazers in gene therapy, infectious diseases, cancer, orphan therapeutics, devices and software.

We provide venture capital funding for seed and early-stage.